These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11851045)

  • 1. [Resistance problems in gastrointestinal infections].
    Krause M
    Ther Umsch; 2002 Jan; 59(1):36-40. PubMed ID: 11851045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Helicobacter pylori resistance to metronidazole and clarithromycin in Brazilian children and adolescents.
    Ogata SK; Godoy AP; da Silva Patricio FR; Kawakami E
    J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):645-8. PubMed ID: 23403439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in resistance rates of H. pylori isolates to metronidazole and tetracycline--comparison of three 3-year studies.
    Siavoshi F; Saniee P; Latifi-Navid S; Massarrat S; Sheykholeslami A
    Arch Iran Med; 2010 May; 13(3):177-87. PubMed ID: 20433221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Susceptibility of 36 Helicobacter pylori clinical isolates to four first-line antibiotics and virulence factors].
    Díaz-Reganon J; Alarcón T; Domingo D; López-Brea M
    Rev Esp Quimioter; 2006 Mar; 19(1):34-8. PubMed ID: 16688289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple therapy with high-dose proton-pump inhibitor, amoxicillin, and doxycycline is useless for Helicobacter pylori eradication: a proof-of-concept study.
    Almeida N; Romãozinho JM; Donato MM; Luxo C; Cardoso O; Cipriano MA; Marinho C; Sofia C
    Helicobacter; 2014 Apr; 19(2):90-7. PubMed ID: 24506175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori eradication therapy.
    Suzuki H; Nishizawa T; Hibi T
    Future Microbiol; 2010 Apr; 5(4):639-48. PubMed ID: 20353303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan.
    Hu CT; Wu CC; Lin CY; Cheng CC; Su SC; Tseng YH; Lin NT
    J Gastroenterol Hepatol; 2007 May; 22(5):720-3. PubMed ID: 17444862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Resistance to antibiotics used in Helicobacter pylori infection in children].
    Maciorkowska E; Kaczmarski M; Kowalczuk J; Kondej-Muszyńska K; Roszko I; Cieśla J; Zielińska A; Musaibili S
    Pol Merkur Lekarski; 2004 Jun; 16(96):543-6. PubMed ID: 15510893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Important bacterial gastrointestinal pathogens in children: a pathogenesis perspective.
    Amieva MR
    Pediatr Clin North Am; 2005 Jun; 52(3):749-77, vi. PubMed ID: 15925661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
    Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
    Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
    Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
    Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic susceptibility of Helicobacter pylori in central Germany and its relationship with the number of eradication therapies.
    Selgrad M; Meissle J; Bornschein J; Kandulski A; Langner C; Varbanova M; Wex T; Tammer I; Schlüter D; Malfertheiner P
    Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1257-60. PubMed ID: 23863261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial.
    Chung JW; Jung YK; Kim YJ; Kwon KA; Kim JH; Lee JJ; Lee SM; Hahm KB; Lee SM; Jeong JY; Yun SC
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1675-80. PubMed ID: 22849546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibiotic resistance: infections of the upper respiratory tract and bronchi. When are antibiotics necessary?].
    Zellweger C; Täuber MG
    Ther Umsch; 2002 Jan; 59(1):21-9. PubMed ID: 11851042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori isolates recovered from gastric biopsies of patients with gastro-duodenal pathologies in Cameroon: current status of antibiogram.
    Ndip RN; Malange Takang AE; Ojongokpoko JE; Luma HN; Malongue A; Akoachere JF; Ndip LM; MacMillan M; Weaver LT
    Trop Med Int Health; 2008 Jun; 13(6):848-54. PubMed ID: 18384477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
    Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
    Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of resistance of Helicobacter pylori to antibiotics on the Helicobacter pylori eradication regimens].
    Cheng H; Hu FL; Li J
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(38):2679-82. PubMed ID: 17199976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment antimicrobial susceptibility-guided vs. clarithromycin-based triple therapy for Helicobacter pylori eradication in a region with high rates of multiple drug resistance.
    Park CS; Lee SM; Park CH; Koh HR; Jun CH; Park SY; Lee WS; Joo YE; Kim HS; Choi SK; Rew JS
    Am J Gastroenterol; 2014 Oct; 109(10):1595-602. PubMed ID: 25091062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Double blind randomized multicentre study of a seven-day eradication regime of Helicobacter pylori by omeprazole, clarithromycin and ornidazole vs. omeprazole, clarithromycin and metronidazole].
    Díte P; Kunovská M; Pulgretová D; Woznica V; Petrtýl J; Hůlek P; Pásková J; Dostalík Z; Novotný I; Procházka V; Hegyi P; Zelenková J; Samek M; Králová Z; Vyhnálek P; Matejovic F; Weinberg J; Kyzeková J
    Vnitr Lek; 2002 Oct; 48(10):976-80. PubMed ID: 16737149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
    Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
    Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.